• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最小化内源性隐蔽质粒以构建用于1917年志贺氏菌的无抗生素表达系统。

Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Nissle 1917.

作者信息

Zhou Siyan, Zhao Linlin, Zuo Wenjie, Zheng Yilin, Zhang Ping, Sun Yanan, Wang Yang, Du Guocheng, Kang Zhen

机构信息

The Science Center for Future Foods, Jiangnan University, Wuxi, 214122, China.

The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.

出版信息

Synth Syst Biotechnol. 2024 Jan 25;9(1):165-175. doi: 10.1016/j.synbio.2024.01.006. eCollection 2024 Mar.

DOI:10.1016/j.synbio.2024.01.006
PMID:38348398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10859263/
Abstract

The probiotic bacterium Nissle 1917 (EcN) holds significant promise for use in clinical and biological industries. However, the reliance on antibiotics to maintain plasmid-borne genes has overshadowed its benefits. In this study, we addressed this issue by engineering the endogenous cryptic plasmids pMUT1 and pMUT2. The non-essential elements were removed to create more stable derivatives pMUT1NR△ and pMUT2HBC△. Synthetic promoters by integrating binding motifs on sigma factors were further constructed and applied for expression of heparinase III and the biosynthesis of ectoine. Compared to traditional antibiotic-dependent expression systems, our newly constructed antibiotic-free expression systems offer considerable advantages for clinical and synthetic biology applications.

摘要

益生菌菌株Nissle 1917(EcN)在临床和生物产业中具有巨大的应用潜力。然而,依赖抗生素来维持质粒携带的基因掩盖了它的优势。在本研究中,我们通过对内生隐蔽质粒pMUT1和pMUT2进行工程改造来解决这个问题。去除了非必需元件以创建更稳定的衍生物pMUT1NR△和pMUT2HBC△。通过整合sigma因子上的结合基序构建了合成启动子,并将其应用于肝素酶III的表达和四氢嘧啶的生物合成。与传统的依赖抗生素的表达系统相比,我们新构建的无抗生素表达系统在临床和合成生物学应用中具有显著优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/27cd990f3baa/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/de9b100d2c06/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/943f6cff4b85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/fdf53a2ca1d4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/fb5628252739/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/faab6b668a7d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/319db4bfbee2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/27cd990f3baa/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/de9b100d2c06/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/943f6cff4b85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/fdf53a2ca1d4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/fb5628252739/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/faab6b668a7d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/319db4bfbee2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e628/10859263/27cd990f3baa/gr7.jpg

相似文献

1
Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Nissle 1917.最小化内源性隐蔽质粒以构建用于1917年志贺氏菌的无抗生素表达系统。
Synth Syst Biotechnol. 2024 Jan 25;9(1):165-175. doi: 10.1016/j.synbio.2024.01.006. eCollection 2024 Mar.
2
CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in Nissle 1917.基于CRISPR的1917株大肠杆菌中隐蔽质粒代谢负担的消除及分析
Eng Life Sci. 2019 Jun 3;19(6):478-485. doi: 10.1002/elsc.201900003. eCollection 2019 Jun.
3
Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering.提高益生菌大肠杆菌 Nissle 1917 中隐秘质粒的稳定性,用于无抗生素途径工程。
Appl Microbiol Biotechnol. 2023 Aug;107(16):5257-5267. doi: 10.1007/s00253-023-12662-6. Epub 2023 Jul 5.
4
Plasmid Vectors for Selection-Free Use with the Probiotic Nissle 1917.用于无选择使用益生菌 1917 的质粒载体。
ACS Synth Biol. 2021 Jan 15;10(1):94-106. doi: 10.1021/acssynbio.0c00466. Epub 2020 Dec 10.
5
Constructing an Antibiotic-Free Protein Expression System for Ovalbumin Biosynthesis in Probiotic Nissle 1917.构建无抗生素蛋白表达系统用于益生菌 Nissle 1917 中卵清白蛋白的生物合成。
J Agric Food Chem. 2024 Apr 17;72(15):8693-8703. doi: 10.1021/acs.jafc.4c00827. Epub 2024 Apr 4.
6
Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.扩展合成生物学中益生菌大肠杆菌 Nissle 1917 的工具包。
Biotechnol J. 2024 Jan;19(1):e2300327. doi: 10.1002/biot.202300327. Epub 2023 Oct 13.
7
Unveiling the impact of cryptic plasmids curing on Escherichia coli Nissle 1917: massive increase in Ag43c expression.揭示隐秘质粒消除对大肠杆菌Nissle 1917的影响:Ag43c表达大幅增加。
AMB Express. 2024 Apr 28;14(1):48. doi: 10.1186/s13568-024-01681-9.
8
The flagellin hypervariable region is a potential flagella display domain in probiotic Escherichia coli strain Nissle 1917.鞭毛蛋白高变区是益生菌大肠杆菌Nissle 1917中一个潜在的鞭毛展示结构域。
Arch Microbiol. 2016 Sep;198(7):603-10. doi: 10.1007/s00203-016-1219-3. Epub 2016 Apr 12.
9
Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.益生菌大肠杆菌 Nissle 1917 的临床应用的遗传工程。
Appl Microbiol Biotechnol. 2016 Oct;100(20):8693-9. doi: 10.1007/s00253-016-7829-5. Epub 2016 Sep 17.
10
Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples.用于检测粪便样本中益生菌大肠杆菌Nissle 1917菌株的菌株特异性PCR反应的开发。
Res Microbiol. 2003 Jan-Feb;154(1):59-66. doi: 10.1016/s0923-2508(02)00007-4.

引用本文的文献

1
How many plasmids can bacteria carry? A synthetic biology perspective.细菌能携带多少质粒?从合成生物学角度看。
Open Biol. 2025 Jul;15(7):240378. doi: 10.1098/rsob.240378. Epub 2025 Jul 30.
2
A genetic safeguard for eliminating target genes in synthetic probiotics in a gut environment.一种用于在肠道环境中消除合成益生菌中靶基因的基因保护措施。
iScience. 2025 Jun 27;28(8):113027. doi: 10.1016/j.isci.2025.113027. eCollection 2025 Aug 15.
3
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools.炎症性肠病中的肠道微生物群调节:从旧范式到革命性工具

本文引用的文献

1
Minimized antibiotic-free plasmid vector for gene therapy utilizing a new toxin-antitoxin system.利用新型毒素-抗毒素系统的用于基因治疗的最小化无抗生素质粒载体。
Metab Eng. 2023 Sep;79:86-96. doi: 10.1016/j.ymben.2023.07.003. Epub 2023 Jul 13.
2
Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering.提高益生菌大肠杆菌 Nissle 1917 中隐秘质粒的稳定性,用于无抗生素途径工程。
Appl Microbiol Biotechnol. 2023 Aug;107(16):5257-5267. doi: 10.1007/s00253-023-12662-6. Epub 2023 Jul 5.
3
Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications.
Int J Mol Sci. 2025 Mar 27;26(7):3059. doi: 10.3390/ijms26073059.
4
Engineering artificial cross-species promoters with different transcriptional strengths.构建具有不同转录强度的人工跨物种启动子。
Synth Syst Biotechnol. 2024 Aug 8;10(1):49-57. doi: 10.1016/j.synbio.2024.08.003. eCollection 2025.
5
Application of plasmid stabilization systems for heterologous protein expression in Escherichia coli.质粒稳定系统在大肠杆菌中异源蛋白表达的应用。
Mol Biol Rep. 2024 Aug 28;51(1):939. doi: 10.1007/s11033-024-09881-z.
将大肠杆菌 Nissle 1917 工程化为治疗和工业应用的微生物底盘。
Biotechnol Adv. 2023 Oct;67:108202. doi: 10.1016/j.biotechadv.2023.108202. Epub 2023 Jun 19.
4
Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering.利用蛋白质和代谢工程开发生产β-丙氨酸的益生菌大肠杆菌 Nissle 1917。
Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2277-2288. doi: 10.1007/s00253-023-12477-5. Epub 2023 Mar 16.
5
A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation.红光控制的益生菌生物系统,用于原位肠道-大脑轴调节。
Biomaterials. 2023 Mar;294:122005. doi: 10.1016/j.biomaterials.2023.122005. Epub 2023 Jan 20.
6
Gene knockdown by structure defined single-stem loop small non-coding RNAs with programmable regulatory activities.通过具有可编程调控活性的结构定义单茎环小非编码RNA实现基因敲低。
Synth Syst Biotechnol. 2022 Nov 30;8(1):86-96. doi: 10.1016/j.synbio.2022.11.006. eCollection 2023 Mar.
7
Directed evolution of colE1 plasmid replication compatibility: a fast tractable tunable model for investigating biological orthogonality.定向进化 colE1 质粒复制兼容性:一种快速、易于处理的可调模型,用于研究生物正交性。
Nucleic Acids Res. 2022 Sep 9;50(16):9568-9579. doi: 10.1093/nar/gkac682.
8
CRISPRimediated suppression of Nissle 1917 virulence factors: A strategy for creating an engineered probiotic using gene suppression.CRISPR介导的对Nissle 1917毒力因子的抑制:一种利用基因抑制创建工程益生菌的策略。
Front Nutr. 2022 Aug 1;9:938989. doi: 10.3389/fnut.2022.938989. eCollection 2022.
9
Systematic and quantitative view of the antiviral arsenal of prokaryotes.原核生物抗病毒武器库的系统和定量分析。
Nat Commun. 2022 May 10;13(1):2561. doi: 10.1038/s41467-022-30269-9.
10
Engineered Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment.工程化的 Nissle 1917 菌株,具有尿酸氧化酶和氧气回收系统,用于治疗高尿酸血症。
Gut Microbes. 2022 Jan-Dec;14(1):2070391. doi: 10.1080/19490976.2022.2070391.